(Q35113474)

6 August 2017

1 reference

title

Barrett's esophagus: an update (English)

1 reference

6 August 2017

1 reference

Massimo Conio

1

1 reference

6 August 2017

Gabriella Lapertosa

series ordinal

2

1 reference

6 August 2017

Sabrina Blanchi

series ordinal

3

1 reference

6 August 2017

Rosangela Filiberti

series ordinal

4

1 reference

6 August 2017

publication date

1 May 2003

1 reference

Critical Reviews in Oncology Hematology

6 August 2017

published in

1 reference

6 August 2017

volume

46

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

187-206

1 reference

Barrett's esophagus: age, prevalence, and extent of columnar epithelium

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

1 reference

7 January 2021

Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Familial gastroesophageal reflux and development of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Gastroesophageal reflux disease in monozygotic and dizygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Familial clustering of reflux symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Barrett's esophagus: prevalence in symptomatic relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Epidemiology of columnar-lined esophagus and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Transient lower esophageal sphincter relaxation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Motility abnormalities in the columnar-lined esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Comparison of the main oesophageal pathophysiological characteristics between short- and long-segment Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Correlation of oesophageal acid exposure with Barrett's oesophagus length

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

The role of pepsin in acid injury to esophageal epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Acid and bile reflux in Barrett's esophagus: a tale of two evils

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Biomarkers in Barrett esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

The esophagogastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett's esophagus, and the latter's progression toward esophageal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Experimental columnar metaplasia in the canine oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Morphological characterization of the squamocolumnar junction of the esophagus in patients with and without Barrett's epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Barrett's esophagus and reflux esophagitis: is there a missing link?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

1 reference

7 January 2021

Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Mucin histochemistry of the columnar epithelium of the oesophagus: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Mucin histochemical analysis in the interpretation of Barrett's esophagus. Results of a multicenter study. The Operative Group for the Study of Esophageal Precancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Dysplasia in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Observer variation in the diagnosis of dysplasia in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Prevalence of metaplasia at the gastro-oesophageal junction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Short segment Barrett's oesophagus: prevalence, diagnosis and associations

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Prolonged measurement of lower oesophageal sphincter function in patients with intestinal metaplasia at the oesophagogastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

The gastric cardia in Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Role ofHelicobacter pylori cagA+ strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Gastric cardia inflammation: role of Helicobacter pylori infection and symptoms of gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Intestinal metaplasia of the gastric cardia: A prospective study with enhanced magnification endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

The gastric cardia: fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Heterotopic gastric mucosa of the cervical esophagus: a case of high-grade dysplasia treated with argon plasma coagulation and a case of adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Risk factors for Barrett's esophagus: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Rising incidence of adenocarcinoma of the esophagus and gastric cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Gastro-oesophageal cancer: death at the junction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

The diagnosis of Barrett's esophagus: goblets, goblets, goblets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Comparison of methylene blue-directed biopsies and conventional biopsies in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Endoscopic fluorescence spectroscopy in the upper GI tract for the detection of GI cancer: initial experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Endosonography in the evaluation of patients with Barrett's esophagus and high-grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Clinical outcome of endoscopic mucosal resection for superficial GI lesions and the role of high-frequency US probe sonography in an American population

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Diagnosis of specialized intestinal metaplasia by optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Optical coherence tomography of the esophagus and proximal stomach in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Upper endoscopy as a screening and surveillance tool in esophageal adenocarcinoma: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Surveillance and survival in Barrett's adenocarcinomas: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

National Cancer Data Base report on esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Does surveillance endoscopy improve life expectancy in those with Barrett's esophagus?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Cost effectiveness of detecting Barrett's cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

The economic impact of the diagnosis of dysplasia in Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Clinical practice. Barrett's Esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Barrett's esophagus: an overrated cancer risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Recent developments in the molecular characterization of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Proliferative characteristics of intestinalized mucosa in the distal esophagus and gastroesophageal junction (short-segment Barrett's esophagus): a case control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Role of p53 assessment in management of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

p53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

p53 and neoplastic progression in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Clinicopathologic and molecular analysis of high-grade dysplasia and early adenocarcinoma in short- versus long-segment Barrett esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Src activation in malignant and premalignant epithelia of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Evaluation of c-erbB-2 overexpression and Her-2/neu gene copy number heterogeneity in Barrett's adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Expression of cyclin B1 in the metaplasia-dysplasia-carcinoma sequence of Barrett esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Abnormal expression of the E-cadherin-catenin complex in dysplastic Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

An update on strategies for eradication of Barrett's mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Maximal acid reflux control for Barrett's oesophagus: feasible and effective

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Dysplasia and adenocarcinoma after classic antireflux surgery in patients with Barrett's esophagus: the need for long-term subjective and objective follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

The adoption of ablation therapy for Barrett's esophagus: a cohort study of gastroenterologists.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

High-grade dysplasia within Barrett's esophagus: controversies regarding clinical opinions and approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Transhiatal esophagectomy: clinical experience and refinements

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

A hospital's annual rate of esophagectomy influences the operative mortality rate

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Impact of hospital volume on operative mortality for major cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

1 reference

7 January 2021

Photodynamic therapy of Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Endoscopic resection of adenocarcinoma arising in a tongue of Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopic surveillance programme. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Barretts's esophagus: does an antireflux procedure reduce the need for endoscopic surveillance?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

Barrett's esophagus. Prevalence and incidence of adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900123-3

7 January 2021

10.1016/S1040-8428(02)00123-3

Identifiers

DOI

1 reference

release_zbombse3tjblxdn6c76kchqhym

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zbombse3tjblxdn6c76kchqhym

24 November 2022

mapped directly with Wikidata item

1 reference